๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This is a pilot, explorative, study to test the feasibility and safety of s...
Status
Withdrawn
Location
Unit of Oncology - Ospedali Riuniti of Bergamo
Start Date
2010-11
Trial ID
NCT01275612
Treatments Being Tested
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
Hydroxycitrate (HCA) is a compound extracted from the fruit, Garcinia Cambo...
Status
Completed
Location
New York University School of Medicine
Start Date
2018-10-04
Trial ID
NCT03348228
Treatments Being Tested
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
This is a Phase II parallel group randomized controlled trial with 294 adol...
Status
Recruiting
Location
UConn Health
Start Date
2024-11-26
Trial ID
NCT06395467
Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for...
Status
Recruiting
Location
Fox Chase Cancer Center
Start Date
2023-08-01
Trial ID
NCT05880667
Treatments Being Tested
Background: Millions of people each year sustain injuries, have tumors surg...
Status
Recruiting
Location
Johns Hopkins University School of Medicine
Start Date
2011-07-21
Trial ID
NCT01459107
The aim of our study is to investigate the effects of cervical stabilizatio...
Status
Unknown
Location
Multiple Locations
Start Date
2022-02
Trial ID
NCT05202171
Treatments Being Tested
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2025-08-10
Trial ID
NCT07106671
Treatments Being Tested
Dexmedetomidine (Precedex, Hospira) is a "super" selective alpha2-agonist -...
Status
Completed
Location
Johns Hopkins University
Start Date
2005-05
Trial ID
NCT00390871
Treatments Being Tested